Predictors for Prehospital Delay in Stroke Treatment

NCT03759691 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2021-04-28

No results posted yet for this study

Summary

Stroke is the second-leading cause of death worldwide and a leading cause of long-term disability. Annually 12,000 people in Denmark suffers a stroke; half of them will have long-term disabilities that may affect the activities of daily living. In addition to substantial individual suffering, stroke is also associated with considerable costs to society. Acute reperfusion therapies started within 4.5 to 6 hours (in some up to 24 hours) from symptom onset for acute ischaemic stroke (AIS) have revolutionized the acute stroke treatment and considerably improved the overall prognosis and mortality. However, only 15-25% of Danish patients are eligible to acute treatment. Numerous attempts to reduce both prehospital and in-hospital delay in stroke have been made, but much time is still lost in the prehospital phase.

Many stroke patients do not recognize their own symptoms as signs of a stroke or do not understand the importance of calling Emergecy Medical Services (EMS) immediately. Others cannot call for help unless they have a bystander, because of cognitive impairment or aphasia. Some patients have a wait-and-see attitude, contact their GP or out-of-hours GP, which also can increase the delay. Educational stroke campaigns can increase knowledge, improve help-seeking behaviour and increase the number of patients eligible for reperfusion therapies. The foundation TrygFonden is planning a national stroke campaign in 2019.

Aims:

1. To explore the knowledge of stroke in stroke patients and bystanders.
2. To explore the process from onset of symptoms until admission to hospital and the reasons for prehospital delay.
3. To explore the association between stroke knowledge, help-seeking behaviour and receiving revascularization therapy.
4. To evaluate the immediate effect of the national campaign six months after initiation.

Material and methods:

Study 1:

Structured interviews of stroke patients (and bystanders) admitted to the Department of Neurology at Aarhus University Hospital and Regional Hospital West Jutland (Holstebro). The investigators will use the patient's medical record (EPJ) and the Danish Stroke Register (DSR) and map the patient's route from onset of symptoms to admission to stroke centre, including contact to general practitioner (GP), out-of-hours GP or Emergency Medical Services (EMS). For patients who have been in contact with their GP, the GP will receive an electronic questionnaire to explore the time- and event pathway from first contact until admitting the patient to hospital. The investigators will interview 500 patients and approximately 300 bystanders over a period of 3 months.

Study 2:

The investigators will evaluate the effect of the national stroke campaign by conducting a similar study in 2020 when the campaign has been running for six months.

Perspectives:

This study will provide new information about stroke patients and bystanders, their knowledge of stroke and their help-seeking behaviour. If more knowledge about the factors that cause prehospital delay in stroke treatment are obtained, the investigators will know which areas to focus on in the future to improve the outcome for stroke patients. Part of this project will examine the effect of TrygFondens national stroke campaign, which is expected to have impact on general knowledge and help-seeking behaviour. If more people know the core symptoms of stroke, hopefully more people will also know how to react to these symptoms by calling EMS. This will eventually increase reperfusion therapy rates, considerably improve stroke morbidity and mortality and reduce both individual suffering and the societal costs.

Conditions

Interventions

BEHAVIORAL

Structured interview

Interview contains questions about stroke knowledge and help-seeking behaviour on the day the stroke occured.

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER
  • Research Unit for General Practice, Aarhus University

    collaborator OTHER
  • Regional Hospital West Jutland

    collaborator OTHER
  • TrygFonden, Denmark

    collaborator INDUSTRY
  • University of Aarhus

    lead OTHER

Principal Investigators

  • Grethe Andersen, DMSc · Professor, DMSc

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-28
Primary Completion
2018-05-10
Completion
2020-12-29

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03759691 on ClinicalTrials.gov